Randomized Dose‐Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse ofPlasmodium vivaxMalaria in Thailand

Abstract

WR 238605 is an 8-aminoquinoline developed for the radical cure of Plasmodium vivax. Forty-four P. vivax-infected patients were randomly assigned to